Cargando…
Circulating CXCR5 (+) natural killer cells are expanded in patients with myasthenia gravis
OBJECTIVES: Myasthenia gravis (MG) is a classic autoantibody‐mediated disease in which pathogenic antibodies target postsynaptic membrane components, causing fluctuating skeletal muscle weakness and fatigue. Natural killer (NK) cells are heterogeneous lymphocytes that have gained increasing attentio...
Autores principales: | Ge, Meng‐Ru, Yang, Chun‐Lin, Li, Tao, Du, Tong, Zhang, Peng, Li, Xiao‐Li, Dou, Ying‐Chun, Duan, Rui‐Sheng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10202622/ https://www.ncbi.nlm.nih.gov/pubmed/37223338 http://dx.doi.org/10.1002/cti2.1450 |
Ejemplares similares
-
CXCR5-negative natural killer cells ameliorate experimental autoimmune myasthenia gravis by suppressing follicular helper T cells
por: Yang, Chun-Lin, et al.
Publicado: (2019) -
Exosomes derived from statin-modified bone marrow dendritic cells increase thymus-derived natural regulatory T cells in experimental autoimmune myasthenia gravis
por: Zhang, Peng, et al.
Publicado: (2019) -
Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity
por: Zhang, Peng, et al.
Publicado: (2021) -
Correction to: Diabetes mellitus exacerbates experimental autoimmune myasthenia gravis via modulating both adaptive and innate immunity
por: Zhang, Peng, et al.
Publicado: (2021) -
Immunotherapy choice and maintenance for generalized myasthenia gravis in China
por: Zhang, Chao, et al.
Publicado: (2020)